Cancer stem cells (CSCs) hijack stromal signaling to evade immunity and support metastasis, particularly in breast and pancreatic cancers, where CSC–fibroblast crosstalk via IL-6 and FAP plays a critical role [183,184,185]. This evidence concerns the gene FAP and pancreatic neoplasm.